{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:30:35Z","timestamp":1793651435759,"version":"4.5.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.toxrep.2026.102296","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:18:13Z","timestamp":1781738293000},"page":"102296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Investigation into the oral toxicity profile of TruCBN\u2122"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5279-2036","authenticated-orcid":false,"given":"Mark R.","family":"Bauter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaughn","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Paul","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"DiCarlo-Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.toxrep.2026.102296_bib1","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.3390\/plants11212896","article-title":"Cannabinol: history, syntheses, and biological profile of the greatest \u201cMinor\u201d Cannabinoid","volume":"11","author":"Maioli","year":"2022","journal-title":"Plants"},{"issue":"17","key":"10.1016\/j.toxrep.2026.102296_bib2","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1021\/jm0001572","article-title":"Novel cannabinol probes for CB1 and CB2 cannabinoid receptors","volume":"43","author":"Mahadevan","year":"2000","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102296_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23495-0","article-title":"Cannabinoid receptor 2 (Cb2r) mediates cannabinol (CBN) induced developmental defects in zebrafish","volume":"12","author":"Amin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxrep.2026.102296_bib4","unstructured":"Jensen R.P., Hartung V., inventors; Florascience Inc., assignee. Methods of preparing cannabinoids or derivatives thereof. US patent 12,371,412 B2. 2025. Available from: \u3008https:\/\/patents.google.com\/patent\/US12371412B2\u3009."},{"issue":"3","key":"10.1016\/j.toxrep.2026.102296_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166325","article-title":"Cannabinol modulates neuroprotection and intraocular pressure: a potential multi-target therapeutic intervention for glaucoma","volume":"1868","author":"Somvanshi","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102296_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081908","article-title":"Cannabinol inhibits cellular proliferation, invasion, and angiogenesis of neuroblastoma via novel miR-34a\/tRiMetF31\/PFKFB3 Axis","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.toxrep.2026.102296_bib7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/biomedicines12061340","article-title":"Cannabinol regulates the expression of cell cycle-associated genes in motor neuron-like NSC-34: a transcriptomic analysis","volume":"12","author":"Trainito","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.toxrep.2026.102296_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2022.01.001","article-title":"Cannabinol inhibits oxytosis\/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors","volume":"180","author":"Liang","year":"2022","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.toxrep.2026.102296_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103692","article-title":"Cannabinol (CBN) alleviates age-related cognitive decline by improving synaptic and mitochondrial health","volume":"84","author":"Dar","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.toxrep.2026.102296_bib10","article-title":"Cannabinol modulates the endocannabinoid system and shows TRPV1-mediated anti-inflammatory properties in human keratinocytes","author":"Di Meo","year":"2024","journal-title":"BioFactors (Oxf. Engl.)"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102296_bib11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3390\/ph17080977","article-title":"A randomized, double-blind, placebo-controlled trial to assess the effectiveness and safety of melatonin and three formulations of Floraworks proprietary TruCBN\u2122 for improving sleep","volume":"17","author":"Kolobaric","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.toxrep.2026.102296_bib12","doi-asserted-by":"crossref","DOI":"10.1089\/can.2021.0006","article-title":"Cannabinol and sleep: separating fact from fiction","author":"Corroon","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.toxrep.2026.102296_bib13","article-title":"A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats","author":"Arnold","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102296_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071148","article-title":"Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (\u201cCUPID\u201d study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial","volume":"13","author":"Lavender","year":"2023","journal-title":"BMJ Open."},{"issue":"3","key":"10.1016\/j.toxrep.2026.102296_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1037\/pha0000682","article-title":"A double-blind, randomized, placebo-controlled study of the safety and effects of cannabinol (CBN) with and without cannabidiol (CBD) on sleep quality","volume":"32","author":"Bonn-Miller","year":"2024","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102296_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxrep.2026.102296_bib17","series-title":"Institute of Laboratory Animal Research, Division of Earth and Life Studies","article-title":"Guide for the care and use of laboratory animals","author":"National Research Council of the National Academies","year":"2011"},{"key":"10.1016\/j.toxrep.2026.102296_bib18","unstructured":"Product Safety Labs, Study Number 64290 (2026). TruCBN\u2122: An oral toxcitiy\/tolerability study in rats."},{"key":"10.1016\/j.toxrep.2026.102296_bib19","unstructured":"Product Safety Labs, Study Number 64291 (2024). TruCBN\u2122: A 14-day repeat dose oral gavage range-finding study in rats."},{"key":"10.1016\/j.toxrep.2026.102296_bib20","unstructured":"Product Safety Labs, Study Number 66124 (2025). TruCBN\u2122: A 90-day oral gavage toxicity study in rats with a 28-day recovery period."},{"issue":"3","key":"10.1016\/j.toxrep.2026.102296_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice**College of Pharmacy, University of Nebraska, Lincoln 8","volume":"46","author":"Dunham","year":"1957","journal-title":"J. Am. Pharm. Assoc. (Sci. Ed. )"},{"issue":"4","key":"10.1016\/j.toxrep.2026.102296_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantitative measurement of motor in-coordination in naive mice using an accelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.toxrep.2026.102296_bib23","series-title":"Intuitive Biostatistics, a Nonmathematical Guide to Statistical Thinking (3rd Edition)","author":"Motulsky","year":"2014"},{"issue":"3","key":"10.1016\/j.toxrep.2026.102296_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2307\/2528490","article-title":"New tables for multiple comparisons with a control","volume":"20","author":"Dunnett","year":"1964","journal-title":"Biometrics"},{"key":"10.1016\/j.toxrep.2026.102296_bib25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/01621459.1980.10477552","article-title":"Pairwise multiple comparisons in the unequal variance case","volume":"75","author":"Dunnett","year":"1980","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.toxrep.2026.102296_bib26","first-page":"268","article-title":"Properties of sufficiency and statistical tests","volume":"160","author":"Bartlett","year":"1937"},{"key":"10.1016\/j.toxrep.2026.102296_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"10.1016\/j.toxrep.2026.102296_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","article-title":"Use of ranks in one-criterion analysis of variance","volume":"47","author":"Kruskal","year":"1952","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.toxrep.2026.102296_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","article-title":"Multiple contrasts using rank sums","volume":"6","author":"Dunn","year":"1964","journal-title":"Technometrics"},{"key":"10.1016\/j.toxrep.2026.102296_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxlet.2014.06.005","article-title":"Review of approaches to the recording of background lesions in toxicologic pathology studies in rats","author":"McInnes","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxrep.2026.102296_bib31","series-title":"Background Lesions in Laboratory Animals: A Color Atlas","first-page":"111","article-title":"Wistar and Sprague\u2013Dawley rats","author":"McInnes","year":"2012"},{"key":"10.1016\/j.toxrep.2026.102296_bib32","series-title":"Pathology of Laboratory Rodents and Rabbits","first-page":"119","article-title":"Rat","author":"Barthold","year":"2016"},{"key":"10.1016\/j.toxrep.2026.102296_bib33","article-title":"Health benefits, pharmacological properties, and metabolism of cannabinol: a comprehensive review","volume":"213","author":"Khouchlaa","year":"2024","journal-title":"Ind. Crops Prod. (Print. )"},{"issue":"11","key":"10.1016\/j.toxrep.2026.102296_bib34","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","article-title":"Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes","volume":"79","author":"Yamaori","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102296_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.14120","article-title":"Preclinical Evidence for a drug\u2013drug interaction between cannabinol and melatonin","volume":"136","author":"Anderson","year":"2025","journal-title":"Basic. & Clin. Pharmacol. & Toxicol."},{"issue":"7","key":"10.1016\/j.toxrep.2026.102296_bib36","first-page":"391","article-title":"Cannabinoids in neurodegenerative disorders and stroke","volume":"7","author":"Fern\u00e1ndez-Ruiz","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.toxrep.2026.102296_bib37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/ph13100322","article-title":"Anti-stress properties of atypical antipsychotics","volume":"13","author":"Sanson","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102296_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00213-012-2697-x","article-title":"Cannabinol and cannabidiol exert opposing effects on rat feeding patterns","volume":"223","author":"Farrimond","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.toxrep.2026.102296_bib39","first-page":"2579","article-title":"Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data","volume":"10","author":"EFSA","year":"2012","journal-title":"EFSA J."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:04:16Z","timestamp":1793649856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750026000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S2214750026000983"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102296","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation into the oral toxicity profile of TruCBN\u2122","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102296"}}